Advanced Clinical Data Science: NSCLC EGFR TKI Feasibility Resistance Analysis with TrialMind | Jimeng Sun
Advanced Clinical Data Science: NSCLC EGFR TKI Feasibility Resi…
5.7K views3 weeks ago
linkedin.com
Show Me the Data™: Post-TKI Sequencing in EGFR-Mutated NSCLC—Optimizing Current Strategies and Preparing for New Treatment Modalities Date: Friday, January 23, 2026 Time: 1:00 PM - 2:00 PM ET To claim CME credits, please view the stream at https://event.arraylive.com/app/login/2e9450f9-3ca2-4401-ada6-5d83ff367afd/virtualattendee | Physicians' Education Resource
1:03:37
Show Me the Data™: Post-TKI Sequencing in EGFR-Mutated NSC…
15 views1 month ago
FacebookPhysicians' Education Resource
ESMO 2025 Insights: Sacituzumab Tirumotecan vs. Platinum-Based Chemo for EGFRm NSCLC After EGFR-TKI Progression - OptiTROP-Lung04 Study
ESMO 2025 Insights: Sacituzumab Tirumotecan vs. Platinum-Based …
4 months ago
vumedi.com
Treatment of TKI-Refractory EGFR-Mutant NSCLC | OncLive
Treatment of TKI-Refractory EGFR-Mutant NSCLC | OncLive
2K viewsNov 12, 2021
onclive.com
Treating Driver Mutation Negative NSCLC | OncLive
Treating Driver Mutation Negative NSCLC | OncLive
Feb 27, 2015
onclive.com
Experts on Second-Line Treatment Options for EGFR TKI-Resistant NSCLC | OncLive
Experts on Second-Line Treatment Options for EGFR TKI-Resistant N…
Dec 23, 2022
onclive.com
Dr. Goldberg Discusses Resistance to EGFR TKI Therapy in NSCLC | OncLive
Dr. Goldberg Discusses Resistance to EGFR TKI Therapy in NSCLC | …
Mar 8, 2018
onclive.com
Overcoming EGFR Inhibitor Resistance in NSCLC | OncLive
3 months ago
onclive.com
WCLC 2025 Insights: HARMONi Phase 3 Trial - Ivonescimab Chem…
39 views5 months ago
vumedi.com
Options for NTRK Rearranged NSCLC
82 viewsJul 24, 2024
vumedi.com
4:56
Current Treatment Landscape for EGFR-Mutated NSCLC | OncLive
Oct 12, 2023
onclive.com
Unmet Needs in NSCLC Treatment | AJMC
Jun 22, 2022
ajmc.com
Patritumab Deruxtecan (HER3-DXd) in EGFR-Mutated NSCLC Followin…
Oct 6, 2023
onclive.com
Traveling Through the Lung Cancer Treatment Paradigm: Taking TKI-R…
Mar 15, 2023
onclive.com
Maintenance Combination Therapy in NSCLC | OncLive
Feb 27, 2015
onclive.com
ALK Inhibitor Sequencing in NSCLC | OncLive
Jan 31, 2017
onclive.com
3:48
Amivantamab Accolades Add Up for NSCLC | AJMC
Sep 27, 2024
ajmc.com
Chemotherapy Regimens in Metastatic NSCLC | OncLive
Feb 27, 2015
onclive.com
Dr. Cho on the Updated Efficacy of Repotrectinib in TKI-Naïve ROS1 …
Jan 31, 2021
onclive.com
Afatinib Plus Cetuximab in Resistant NSCLC | OncLive
3 weeks ago
onclive.com
Maintenance Therapy Clinical Trials for NSCLC | OncLive
4 months ago
onclive.com
Maintenance Nab-Paclitaxel in Squamous NSCLC | OncLive
2 weeks ago
onclive.com
EGFR TKIs as Adjuvant Therapy in NSCLC
Jul 26, 2018
onclive.com
Managing Resistance to EGFR TKIs in NSCLC
Jul 26, 2018
onclive.com
The Importance of Targeting RET in NSCLC | OncLive
2 weeks ago
onclive.com
5:48
EGFR-Mutated NSCLC: Treatment Options Following Progression o…
Oct 19, 2023
onclive.com
Dr. Paik on Tepotinib in METex14-Mutated NSCLC | OncLive
Jun 27, 2019
onclive.com
3:15
The Prevalence of ROS1 Fusions in Advanced NSCLC | OncLive
9 months ago
onclive.com
Evolution of 1L EGFR TKI Therapy in mNSCLC
211 views11 months ago
vumedi.com
Second- and Third-Generation TKIs in EGFR-Mutated NSCLC | OncLive
1 month ago
onclive.com
See more videos
Static thumbnail place holder